Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System ® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections in Argentina.
Alfredo PalaciosFederico Rodriguez CairoliDario BalanCarlos Rojas-RoqueCarolina Moreno-LópezBarbara BraunFederico AugustovskiAndrés Pichon-RiviereAriel Esteban BardachPublished in: Applied health economics and health policy (2023)
The potential coverage of FSL in patients with T1DM and T2DM with multiple daily insulin injections could be associated with small financial savings considering current technology acquisition costs (FSL and test strips) for social security and the private sector third-party payers in Argentina.